The influence of dexmedetomidine on ischemic rat hippocampus

Brain Research

Volumn 1218, Issue , 2008, Pages 250-256

  Eser, Olcay ^a   Fidan, Huseyin ^a   Sahin, Onder ^a   Cosar, Murat ^b   Yaman, Mehmet ^a   Mollaoglu, Hakan ^a   Songur, Ahmet ^a   Buyukbas, Sadik ^c  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^c SELCUK UNIVERSITY   (Turkey)

Author keywords

Cerebral; Dexmedetomidine; Hippocampus; Injury; Ischemia reperfusion

Indexed keywords

CATALASE; DEXMEDETOMIDINE; MALONALDEHYDE; NITRIC OXIDE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLOOD VESSEL OCCLUSION; BRAIN PERFUSION; BRAIN TISSUE; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; NERVE CELL; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; TRANSIENT ISCHEMIC ATTACK;

ADRENERGIC ALPHA-AGONISTS; ANALYSIS OF VARIANCE; ANIMALS; CATALASE; CYTOKINES; DEXMEDETOMIDINE; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; IN SITU NICK-END LABELING; ISCHEMIA; MALE; MALONDIALDEHYDE; NEURONS; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 46349092911     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.04.045     Document Type: Article

References (47)

1. Aebi H. Catalase. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1974), Academic Pres, New York 673-677
2. Barone F.C., and Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19 8 (1999) 819-834
3. Bas O., Songur A., Sahin O., Mollaoglu H., Ozen O.A., Yaman M., Eser O., Fidan H., and Yagmurca M. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus. Neurochem. Int. 50 3 (2007) 548-554
4. Berti R., Williams A.J., Moffett J.R., Hale S.L., Velarde L.C., Elliott P.J., Yao C., Dave J.R., and Tortella F.C. Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J. Cereb. Blood Flow Metab. 22 9 (2002) 1068-1079
5. Bickler P.E., and Hansen B.M. Alpha 2-adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia. Neuropharmacology 35 6 (1996) 679-687
6. Boscá L., and Hortelano S. Mechanisms of nitric oxide-dependent apoptosis: involvement of mitochondrial mediators. Cell. Signal. 11 4 (1999) 239-244
7. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21 1 (2001) 2-14
8. Cortas N.K., and Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36 (1990) 1440-1443
9. Durak I., Yurtarslanl Z., Canbolat O., and Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin. Chim. Acta. 214 (1993) 103-104
10. Engelhard K., Werner C., Eberspacher E., Bachl M., Blobner M., Hildt E., Hutzler P., and Kochs E. The Effect of the alpha 2-Agonist dexmedetomidine and the N-Methyl-d-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth. Analg. 96 (2003) 524-531
11. Figiel I., and Dzwonek K. TNF alpha and TNF receptor 1 expression in the mixed neuronal-glial cultures of hippocampal dentate gyrus exposed to glutamate or trimethyltin. Brain Res. 1131 (2007) 17-28
12. Fillit H., Ding W.H., Buee L., Kalman J., Altstiel L., Lawlor B., and Wolf-Klein G. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci. Lett. 129 (1991) 318-320
13. Globus M.Y., Busto R., Dietrich W.D., Martinez E., Valdes I., and Ginsberg M.D. Direct evidence for acute and massive norepinephrine release in the hippocampus during transient ischemia. J. Cereb. Blood Flow Metab. 9 (1989) 892-896
14. Ginsberg M.D. Neuroprotection in brain ischemia: an update (parts 1 and 2). Neuroscientist 1 (1995) 95
15. Hoffman W.E., Baughman V.L., and Albrecht R.F. Interaction of catecholamines and nitrous oxide ventilation during incomplete brain ischemia in rats. Anesth. Analg. 77 (1993) 908-912
16. Hoffman W.E., Kochs E., Werner C., Thomas C., and Albrecht R.F. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat: reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthesiology 75 (1991) 328-332
17. Hopkins S.J., and Rothwell N.J. Cytokines and the nervous system.I: expression and recognition. Trends Neurosci. 18 (1995) 83-88
18. Intiso D., Zarrelli M.M., Lagioia G., Di Rienzo F., Checchia De Ambriosio C., Simone P., Tonali P., and Cioffi Dagger R.P. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol. Sci. 24 (2004) 390-396
19. Irmak M.K., Fadillioglu E., Sogut S., Erdogan H., Gulec M., Ozer M., Yagmurca M., and Gozukara M.E. Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell Biochem. Funct. 21 (2003) 283-289
20. Jolkkonen J., Puurunen K., Koistinaho J., Kauppinen R., Haapalinna A., Nieminen L., and Sivenius J. Neuroprotection by the alpha 2-adrenoreceptor agonist, dexmedetomidine, in the rat focal cerebral ischemia. Eur. J. Pharmacol. 372 (1999) 31-36
21. Knoblach S.M., Fan L., and Faden A.I. Early neuronal production of tumor necrosis factor-α after experimental brain injury contributes to neurological impairment. J. Neuroimmunol. 95 (1999) 115-125
22. Lanselot E., Callebert J., Revaud M.L., Boulu R.G., and Plotkine M. Detection of hydroxyl radicals in rat striatum during transient focal cerebral ischemia: possible implication in tissue damage. Neurosci Lett. 197 (1995) 85-88
23. Laudenbach V., Mantz J., Lagercrantz H., Desmonts J.M., Evrard P., and Gressens P. Effects of alpha 2-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine. Anesthesiology 96 (2002) 134-141
24. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., and Feuerstein G.Z. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25 (1994) 1481-1488
25. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
26. Maes M., Lin A., Kenis G., Egyed B., and Bosmans E. The effects of noradrenaline and alpha-2 adrenoceptor agents on the production of monocytic products. Psychiatry Res. 96 (2000) 245-253
27. Martin E., Ramsay G., Mantz J., and Sum-Ping S.T. The role of the alpha 2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J. Intensive Care Med. 18 (2003) 29-41
28. Matsumoto M., Zornow M.H., Rabin B.C., and Maze M. The alpha 2-adrenergic agonist, dexmedetomidine, selectively attenuates ischemia-induced increases in striatal norepinephrine concentrations. Brain Res. 627 (1993) 325-329
29. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., and Nagatsu T. Tumor necrosis factor-alpha (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165 (1994) 208-210
30. Ramsay M.A., and Luterman D.L. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology 101 (2004) 787-790
31. Reeker W., Werner C., Möllenberg O., Mielke L., and Kochs E. High-dose S(+)-ketamine improves neurological outcome following incomplete cerebral ischemia. Can. J. Anaesth. 47 (2000) 572-578
32. Schmidt-Kastner R., Paschen W., Ophoff B.G., and Hossmann K.A. A modified four-vessel occlusion model for inducing incomplete forebrain ischemia in rats. Stroke 20 (1989) 938-946
33. Sharief M.K., Noori M.A., Ciardi M., Cirelli A., and Thompson E.J. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis: correlation with TNF-alpha and blood-brain barrier damage. J. Neuroimmunol. 43 (1993) 15-21
34. Sun Y., Oberley L.W., and Ying L. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34 (1988) 497-500
35. Straub R.H., Herrmann M., Berkmiller G., Frauenholz T., Lang B., Schölmerich J., and Falk W. Neuronal regulation of interleukin 6 secretion in murine spleen: adrenergic and opioidergic control. J. Neurochem. 68 (1997) 1633-1639
36. Szabo C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res. Bull. 41 (1996) 131-141
37. Talke P., and Bickler P.E. Effects of dexmedetomidine on hypoxia evoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology 85 (1996) 551-557
38. Till G.O., Johnson K.J., Kunkel R., and Warda P.A. Intravascular activation of complement and acute lung injury: dependency on neutrophils and toxic oxygen metabolites. J. Clin. Invest. 69 (1982) 1126-1135
39. Tracey K.J., Beutler B., Lowry S.F., Merryweather J., Wolpe S., Milsark I.W., Hariri R.J., Fahey III T.J., Zentella A., Albert J.D., et al. Shock and tissue injury induced by recombinant human cachectin. Science 234 (1986) 470-474
40. Utteridge J.M. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem. 41 (1995) 1819-1828
41. Venn R.M., Bryant A., Hall G.M., and Grounds R.M. Effects of dexmedetomidine on adrenocortical function and the cardiovascular, endocrine and inflammatory responses in postoperative patients needing sedation in the intensive care unit. Br. J. Anaesth. 86 (2001) 650-656
42. Wasowicz W., Neve J., and Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin. Chem. 39 (1993) 2522-2526
43. White B.C., Grossman L.I., and Krause G.S. Brain injury by global ischemia and reperfusion: A theoretical perspective on membrane damage and repair. Neurology 43 (1993) 1656-1665
44. Wintroub B.U. Inflammation and mediators. Int. J. Dermatol. 19 (1980) 436-442
45. Yaman M., Eser O., Cosar M., Bas O., Sahin O., Mollaoglu H., Fidan H., and Songur A. Oral Administration of Avocado Soybean Unsaponifiables (ASU) reduces ischemic damage in the rat hippocampus. Arch. Med. Res. 38 (2007) 489-494
46. Yuyan Z., Kuniaki S., Yuki M., Masahide A., Yoichiro I., and Mitsuru S. Early increase in mRNA levels of pro-inflammatory cytokines and their interactions in the mouse hippocampus after transient global ischemia. Neurosci. Lett. 393 (2006) 122-126
47. Zaremba J., and Losy J. Cytokines in clinical and experimental ischemic stroke. Neurol. Neurochir. Pol. 38 (2004) 57-62